Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
28 hedge funds and large institutions have $1.82M invested in Histogen Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.
37% more capital invested
Capital invested by funds: $1.33M → $1.82M (+$490K)
3% less funds holding
Funds holding: 29 → 28 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JC
JBF Capital
Aspen,
Colorado
|
+$182K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$64.4K |
| 3 |
Renaissance Technologies
New York
|
+$47.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.96K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$177K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$22.4K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$9K |
| 4 |
LPL Financial
San Diego,
California
|
-$6K |
| 5 |
VF
Virtu Financial
New York
|
-$4.63K |
HSTO Hedge Fund Activity: Q4 2019 in Review
28 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2019, worth a combined $1.82M — up 37% from $1.33M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of HSTO and 6 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 4 added.
The largest buyer was JBF Capital, opening a new position worth an estimated $182K. The largest seller was BlackRock, cutting an estimated $177K.
- 28 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2019, down from 29 in Q3 2019.
- Funds reported $1.82M of Histogen Inc. Common Stock stock for Q4 2019, up 37% quarter-over-quarter.
- 6 funds opened new Histogen Inc. Common Stock positions in Q4 2019 and 7 closed out, a net change of -1 holder.
- The largest Histogen Inc. Common Stock buyer in Q4 2019 was JBF Capital, an estimated $182K added.
- The largest Histogen Inc. Common Stock seller in Q4 2019 was BlackRock, an estimated $177K sold.
Based on aggregated 13F filings for Q4 2019.